Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14518714rdf:typepubmed:Citationlld:pubmed
pubmed-article:14518714lifeskim:mentionsumls-concept:C0079500lld:lifeskim
pubmed-article:14518714lifeskim:mentionsumls-concept:C0220847lld:lifeskim
pubmed-article:14518714lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:14518714lifeskim:mentionsumls-concept:C0449560lld:lifeskim
pubmed-article:14518714lifeskim:mentionsumls-concept:C2827666lld:lifeskim
pubmed-article:14518714pubmed:issue2lld:pubmed
pubmed-article:14518714pubmed:dateCreated2003-10-1lld:pubmed
pubmed-article:14518714pubmed:abstractTextWe performed genetic and phenic analyses to evaluate nucleotide and amino-acid sequences of the amino-terminus of the E1 protein of HCV genotype 1b (extracted from databank) and 4a (characterised in this study). The non-synonymous (ka) mutation analysis demonstrated that the genome of genotype 1b was not saturated by variations, with a rate of transition/transversion (s/v) of 1.5, which is similar to the expected ratio (i.e., 2.0). The s/v ratio in genotype 4a isolates was lower (0.98), indicating saturation due long-term variability. Moreover, the genotype 1b sequences showed a higher number of ka mutations (s+v) (mean of 2.8 per sequence) than genotype 4a (mean of 1.5). The introduction of ka mutations resulted in a higher degree of amino acid variability in genotype 4a. In the genome of genotype 1b, each nucleotide mutation introduced new amino acids, with a Granthan distance of 3.35-42.5, whereas for genotype 4a the distances ranged from 48.8 to 102.1. The phenic analysis also indicated different and complex patterns of amino-acid substitution. Finally, diverse isoelectric points and hydrophobicity were predicted for the two genotypes, with a higher acidity for genotype 4a E1 proteins.lld:pubmed
pubmed-article:14518714pubmed:languageenglld:pubmed
pubmed-article:14518714pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14518714pubmed:citationSubsetIMlld:pubmed
pubmed-article:14518714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14518714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14518714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14518714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14518714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14518714pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14518714pubmed:statusMEDLINElld:pubmed
pubmed-article:14518714pubmed:issn0393-974Xlld:pubmed
pubmed-article:14518714pubmed:authorpubmed-author:RapicettaMMlld:pubmed
pubmed-article:14518714pubmed:authorpubmed-author:AngelicoMMlld:pubmed
pubmed-article:14518714pubmed:authorpubmed-author:VillaniSSlld:pubmed
pubmed-article:14518714pubmed:authorpubmed-author:ArgentiniCClld:pubmed
pubmed-article:14518714pubmed:authorpubmed-author:DettoriSSlld:pubmed
pubmed-article:14518714pubmed:issnTypePrintlld:pubmed
pubmed-article:14518714pubmed:volume17lld:pubmed
pubmed-article:14518714pubmed:ownerNLMlld:pubmed
pubmed-article:14518714pubmed:authorsCompleteYlld:pubmed
pubmed-article:14518714pubmed:pagination147-52lld:pubmed
pubmed-article:14518714pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:meshHeadingpubmed-meshheading:14518714...lld:pubmed
pubmed-article:14518714pubmed:articleTitleDifferent levels of variability in subtypes 1b and 4a of hepatitis C viruses.lld:pubmed
pubmed-article:14518714pubmed:affiliationLaboratory of Virology, Unit of Hepatitis Viruses, University of Rome Tor Vergata, Rome, Italy.lld:pubmed
pubmed-article:14518714pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14518714pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14518714lld:pubmed